Results 61 to 70 of about 76,298 (277)

Immunosuppressive Drug Use in Limited Systemic Sclerosis: An International Survey

open access: yesArthritis Care &Research, EarlyView.
Objective Current guidelines recommend immunosuppressive treatment for diffuse cutaneous systemic sclerosis but are less clear on their use in limited cutaneous systemic sclerosis (lcSSc) in the absence of internal organ complications. We conducted an international survey to understand current immunosuppressive drug prescribing patterns in lcSSc ...
Sabrina Hoa   +3 more
wiley   +1 more source

Guidelines for prescribing azathioprine in dermatology

open access: yes
Azathioprine has been available as an immunosuppressive agent for over 40 years, and current routine usage in dermatology is not restricted to licensed indications.
Reynolds NJ, Anstey AV, Wakelin S
core   +5 more sources

Evaluating the Effect of Ginger Extract on Azathioprine-Induced Renal Failure in Mature Female Rats

open access: yesJournal of Ardabil University of Medical Sciences, 2018
  Background & objectives: Azathioprine is widely used for the treatment of autoimmune diseases. It has negative effects on the function of kidney.
Zahra Godarzian, Ebrahim Hosseini
doaj  

Efficacy and safety of treatment with azathioprine in Inflammatory Bowel Diseases: a retrospective monocentric study

open access: yes, 2022
reservedRIASSUNTO Introduzione: L’Azatioprina (AZA) è stata utilizzato nel trattamento delle malattie infiammatorie croniche intestinali (MICI) a partire dalla fine degli anni ’50 e fino all’introduzione dei farmaci biologici ha rappresentato uno dei ...
PAVANATO, MARGHERITA
core  

Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care?

open access: yesArthritis Care &Research, EarlyView.
Objective The objective is to describe and compare demographic, clinical, and serological characteristics of patients with systemic sclerosis (SSc) according to ethnic background. Methods Participants enrolled in the Canadian Scleroderma Research Group cohort who self‐identified to a single ethnicity group were included.
Danick Goulet   +11 more
wiley   +1 more source

Perspectives in clinical research on Azathioprine for steroid-dependent ulcerative colitis

open access: yesFrontiers in Medicine
This study explores the application of Azathioprine in the treatment of ulcerative colitis (UC) and the challenges associated with its long-term use. While short-term studies demonstrate the efficacy of Azathioprine in steroid-dependent UC, long-term ...
Yuan-Ting Qu   +4 more
doaj   +1 more source

Hepatitis related to cytomegalovirus infection in two patients with Crohn’s disease treated with azathioprine

open access: yes, 2000
azathioprine-related side-effects occur in about 15% of treated patients. Liver toxicity is a rare complication of this drug, but is considered, in most cases, a contraindication to the continuation of treatment.
A. RISPO   +13 more
core   +1 more source

Association of Elevated Platelets and C‐Reactive Protein With Severe Disease and Poor Survival in Systemic Sclerosis

open access: yesArthritis Care &Research, EarlyView.
Objective Elevated C‐reactive protein (CRP) levels in systemic sclerosis (SSc) have been linked with severe disease and worse survival, but the role of platelet levels remains unclear. This study examined whether elevated platelet levels, CRP levels, or both are associated with disease severity, progression, and survival in SSc.
Brian S. Lee   +4 more
wiley   +1 more source

Azathioprine induced acute sialadenitis: A case report

open access: yes, 2023
Key clinical message Patients presenting with acute sialadenitis need careful review of their medications. Azathioprine is one of such drugs, which can rarely induce acute sialadenitis.
Izzat Ali M. Khanjar   +2 more
core   +1 more source

Employment Trajectories of Patients With Systemic Lupus Erythematosus and Factors Driving Transitions Between States

open access: yesArthritis Care &Research, EarlyView.
Objective Systemic lupus erythematosus (SLE) significantly impacts employment capacity. This study aimed to investigate the impact of burden of disease activity, damage, and treatment on employment outcomes and transitions in patients with SLE. Methods Using data from a single center, we analyzed employment transitions, adjusted mean disease activity ...
Javier Mencia‐Ledo   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy